Reports

Drug name	NICE TAs	Comments
Brexucabtagene autoleucel	TA893 - Brexucabtagene autoleucel for treating relapsed or refractory B-cell acute lymphoblastic leukaemia in people 26 years and over
Brigatinib (Alunbrig®)	TA571 - Brigatinib for treating ALK-positive advanced non-small-cell lung cancer after crizotinib TA670 - Brigatinib for ALK-positive advanced non-small-cell lung cancer that has not been previously treated with an ALK inhibitor
Brodalumab (Kyntheum®)	TA511 - Brodalumab for treating moderate to severe plaque psoriasis
Brolucizumab (Beovu®)	TA672 - Brolucizumab for treating wet age-related macular degeneration
Budenoside and Formoterol (Symbicort)	TA138 - Inhaled corticosteroids for the treatment of chronic asthma in adults and in children aged 12 years and over	For asthma only. Non-formulary for COPD.
Budesonide 1mg orodispersible tablets (Jorveza®)	TA708 - Budesonide orodispersible tablet for inducing remission of eosinophilic oesophagitis
Bulevirtide	TA896 - Bulevirtide for treating chronic hepatitis D
Buprenorphine S/L tablets#4.10	TA114 - Methadone and buprenorphine for the management of opiod dependence
Cabazitaxel infusion	TA391 - Cabazitaxel for hormone-relapsed metastatic prostate cancer treated with docetaxel TA255 - Cabazitaxel for hormone-refractory metastatic prostate cancer previously treated with a docetaxel-containing regimen
Canagliflozin	TA390 - Canagliflozin, dapagliflozin and empagliflozin as monotherapies for treating type 2 diabetes TA315 - Canagliflozin in combination therapy for treating type 2 diabetes

First page
Previous page
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
Next page
Last page

University Hospitals Birmingham NHS Foundation Trust

Medicines Formulary

Reports